| Target binding properties and cellular activity of afatinib (BIBW 2992), an irreversible ErbB family blocker F Solca, G Dahl, A Zoephel, G Bader, M Sanderson, C Klein, O Kraemer, ... Journal of Pharmacology and Experimental Therapeutics 343 (2), 342-350, 2012 | 956 | 2012 |
| Spectroscopic and photochemical study of inclusion complexes of dimethoxybenzenes with cyclodextrins G Grabner, S Monti, G Marconi, B Mayer, C Klein, G Köhler The Journal of Physical Chemistry 100 (51), 20068-20075, 1996 | 58 | 1996 |
| Threshold-based structure− activity relationships of pyrazines with bell-pepper flavor G Buchbauer, CT Klein, B Wailzer, P Wolschann Journal of Agricultural and Food Chemistry 48 (9), 4273-4278, 2000 | 54 | 2000 |
| Topological distance based 3D descriptors for use in QSAR and diversity analysis CT Klein, D Kaiser, G Ecker Journal of chemical information and computer sciences 44 (1), 200-209, 2004 | 49 | 2004 |
| Similarity based SAR (SIBAR) as tool for early ADME profiling C Klein, D Kaiser, S Kopp, P Chiba, GF Ecker Journal of computer-aided molecular design 16, 785-793, 2002 | 45 | 2002 |
| Neuronal α2δ proteins and brain disorders C Ablinger, SM Geisler, RI Stanika, CT Klein, GJ Obermair Pflügers Archiv-European Journal of Physiology 472 (7), 845-863, 2020 | 44 | 2020 |
| Structural Analysis of Host–Guest Systems. Methyl-substituted Phenols in beta;-Cyclodextrin B Mayer, G Marconi, C Klein, G Köhler, P Wolschann Journal of inclusion phenomena and molecular recognition in chemistry 29, 79-93, 1997 | 43 | 1997 |
| Selective assembly of cyclodextrins on poly (ethylene oxide)–poly (propylene oxide) block copolymers B Mayer, CT Klein, IN Topchieva, G Köhler Journal of computer-aided molecular design 13, 373-383, 1999 | 38 | 1999 |
| A method for predicting the free energies of complexation between β-cyclodextrin and guest molecules CT Klein, D Polheim, H Viernstein, P Wolschann Journal of inclusion phenomena and macrocyclic chemistry 36, 409-423, 2000 | 31 | 2000 |
| Predicting the free energies of complexation between cyclodextrins and guest molecules: linear versus nonlinear models CT Klein, D Polheim, H Viernstein, P Wolschann Pharmaceutical research 17, 358-365, 2000 | 31 | 2000 |
| Thiazolyl-dihydro-indazole B Betzemeier, T Brandl, S Breitfelder, R Brueckner, T Gerstberger, ... US Patent 7,691,888, 2010 | 30 | 2010 |
| The structure of higher order C60-fullerene-γ-cyclodextrin complexes G Marconi, B Mayer, CT Klein, G Köhler Chemical physics letters 260 (5-6), 589-594, 1996 | 28 | 1996 |
| Chemical compounds I Sapountzis, P Ettmayer, C Klein, A Mantoulidis, M Steegmaier, S Steurer, ... US Patent App. 12/665,776, 2010 | 25 | 2010 |
| Concentration-dependent pro-and antitumor activities of quercetin in human melanoma spheroids: Comparative analysis of 2D and 3D cell culture models H Hundsberger, A Stierschneider, V Sarne, D Ripper, J Schimon, ... Molecules 26 (3), 717, 2021 | 15 | 2021 |
| Alpha-Carbolines as CDK-1 inhibitors P Sennhenn, A Mantoulidis, M Treu, U Tontsch-Grunt, W Spevak, ... US Patent App. 11/423,008, 2007 | 15 | 2007 |
| Solubility and molecular modeling of triflumizole-β-cyclodextrin inclusion complexes CT Klein, G Köhler, B Mayer, K Mraz, S Reiter, H Viernstein, P Wolschann Journal of inclusion phenomena and molecular recognition in chemistry 22, 15-32, 1995 | 15 | 1995 |
| Sialic acid O-acetylation patterns and glycosidic linkage type determination by ion mobility-mass spectrometry GM Vos, KC Hooijschuur, Z Li, J Fjeldsted, C Klein, RP de Vries, ... Nature Communications 14 (1), 6795, 2023 | 14 | 2023 |
| Chemical compounds I Sapountzis, P Ettmayer, C Klein, A Mantoulidis, S Steurer, I Waizenegger US Patent 8,889,665, 2014 | 13 | 2014 |
| Structure and Spectroscopic Properties of Cyclodextrin Inclusion Complexes. G Koehler, G Grabner, CTH Klein, G Marconi, B Mayer, S Monti, ... Proceedings of the Eighth International Symposium on Cyclodextrins: Budapest …, 1996 | 12 | 1996 |
| Accessible charges in Structure-Activity Relationships. A study on HEPT-Based HIV-1 RT inhibitors CT Klein, L Lawtrakul, S Hannongbua, P Wolschann Scientia Pharmaceutica 68 (1), 25-40, 2000 | 11 | 2000 |
